In summary, we introduced that structurally optimized novel synthetic depsides (SB4 and SB5) bind to the VDAC1/PHB/MMP9 can effectively interfere with key hallmarks of CRC. This evidence concerns the gene VDAC1 and colorectal carcinoma.